Matches in Wikidata for { <http://www.wikidata.org/entity/Q70201443> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q70201443 description "artikull shkencor i botuar më 01 shkurt 1991" @default.
- Q70201443 description "artículu científicu espublizáu en febreru de 1991" @default.
- Q70201443 description "im Februar 1991 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70201443 description "scientific article published on 01 February 1991" @default.
- Q70201443 description "wetenschappelijk artikel" @default.
- Q70201443 description "наукова стаття, опублікована в лютому 1991" @default.
- Q70201443 name "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 name "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 name "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 type Item @default.
- Q70201443 label "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 label "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 label "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 prefLabel "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 prefLabel "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 prefLabel "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 P1433 Q70201443-6910D971-E64F-4263-8C78-95D40E5930A6 @default.
- Q70201443 P1476 Q70201443-2F2DD9BD-66F8-40FA-A596-895F1D56BF3F @default.
- Q70201443 P2093 Q70201443-244E76F1-EC41-449C-B1FD-C50EC0146AA3 @default.
- Q70201443 P2093 Q70201443-2EC3EED8-1A55-4030-A8C3-D2984070DF9D @default.
- Q70201443 P2093 Q70201443-641BD7DC-6B3F-44B7-9B7A-86928701B4A3 @default.
- Q70201443 P2093 Q70201443-66F4C7D0-992B-4398-95F5-B61722342308 @default.
- Q70201443 P2093 Q70201443-740EF17D-7CDC-4577-8195-CBC7535474B9 @default.
- Q70201443 P2093 Q70201443-898897E2-06D1-496B-AFEC-E6B6FE945366 @default.
- Q70201443 P2093 Q70201443-BC70704C-8680-4896-9F57-0E15088FB9EB @default.
- Q70201443 P2093 Q70201443-DBFDB15F-9999-4BB6-9C10-E3B64271C90E @default.
- Q70201443 P2093 Q70201443-ED1EEB78-9162-4E1E-85B9-7C82BC6DC471 @default.
- Q70201443 P2093 Q70201443-FF495C02-EE03-4BFC-81B6-A88FFA99C4FD @default.
- Q70201443 P304 Q70201443-55CD20F4-02ED-43C4-A930-EBEF087B6E14 @default.
- Q70201443 P31 Q70201443-793D412A-CAC9-46B9-B176-3937873FA839 @default.
- Q70201443 P356 Q70201443-05629316-2170-4F12-8D9F-481B6833AEA8 @default.
- Q70201443 P433 Q70201443-3ED786BA-9E6F-4220-981E-AD4F8D858026 @default.
- Q70201443 P478 Q70201443-1FD4C7A9-2601-4E3D-AFA8-69A96EBB532E @default.
- Q70201443 P577 Q70201443-CF7D55DA-7BD6-4697-81C7-7D442EC64586 @default.
- Q70201443 P698 Q70201443-F9AC0F43-FB78-4BA9-A46E-03983E77A2B4 @default.
- Q70201443 P921 Q70201443-5E9E250D-54E7-4F82-A556-438C26B87923 @default.
- Q70201443 P921 Q70201443-CFFB60B6-689A-46C4-A727-8086E35C9AB8 @default.
- Q70201443 P356 000216941 @default.
- Q70201443 P698 2057172 @default.
- Q70201443 P1433 Q15759087 @default.
- Q70201443 P1476 "Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society" @default.
- Q70201443 P2093 "D Fritze" @default.
- Q70201443 P2093 "H Wagner" @default.
- Q70201443 P2093 "K Bremer" @default.
- Q70201443 P2093 "K Possinger" @default.
- Q70201443 P2093 "K Rieche" @default.
- Q70201443 P2093 "M Klee" @default.
- Q70201443 P2093 "M Westerhausen" @default.
- Q70201443 P2093 "P Worst" @default.
- Q70201443 P2093 "R Donhuijsen-Ant" @default.
- Q70201443 P2093 "W Queisser" @default.
- Q70201443 P304 "31-34" @default.
- Q70201443 P31 Q13442814 @default.
- Q70201443 P356 "10.1159/000216941" @default.
- Q70201443 P433 "1" @default.
- Q70201443 P478 "14" @default.
- Q70201443 P577 "1991-02-01T00:00:00Z" @default.
- Q70201443 P698 "2057172" @default.
- Q70201443 P921 Q42824440 @default.
- Q70201443 P921 Q6050805 @default.